Table 2.
Comparison of metabolic and vascular characteristic between control subjects and GDM subjects
| Control subjects | GDM | p-value | |
|---|---|---|---|
| Fasting glucose (mmol/l) |
5.03 ± 0.46 |
5.42 ± 1.64* |
0.01 |
| Fasting insulinemia (μUI/ml) |
10.59 ± 11.1 |
13.19 ± 10.05 |
0.67 |
| Triglyceride (mmol/l) |
1.99 ± 0.23 |
2.4 ± 0.93 |
0.38 |
| Total cholesterol (mmol/l) |
5.12 ± 1.26 |
5.43 ± 1.54** |
<0.0001 |
| HDL cholesterol (mmol/l) |
1.47 ± 0.55 |
1.31 ± 0.3* |
0.018 |
| LDL cholesterol (mmol/l) |
2.59 ± 1.39 |
2.94 ± 1.27 |
0.47 |
| Apo A1 (g/l) |
1.90 ± 0.7 |
1.50 ± 0.34** |
0.001 |
| Apo B (g/l) |
1.36 ± 0.5 |
1.22 ± 0.43 |
0.64 |
| Urea (mmol/l) |
3.83 ± 1.16 |
2.44 ± 0.89* |
0.050 |
| Creatinine (μmol/l) |
49.99 ± 0.15 |
50.74 ± 8.76 |
0.6 |
| HbAc (%) |
5.27 ± 0.5 |
6.7 ± 1.21* |
0.002 |
| HOMA-IR |
1.53 ± 0.51 |
2.38 ± 1.39* |
0.02 |
| Adiponectin (μg/ml) |
10.02 ± 1.1 |
8.58 ± 1.7* |
0.01 |
| IL-6 (pg/ml) |
53.17 ± 1.45 |
77.84 ± 10.98* |
0.002 |
| TNF-α (pg/ml) |
61.75 ± 6.5 |
71.63 ± 12.33 |
0.091 |
| C-reactive protein (mg/dl) |
0.86 ± 1.1 |
0.80 ± 1.4 |
0.716 |
| FSBF endothelium-dependent (%) | 1176.38 ± 531.67 | 344.59 ± 305.81* | 0.037 |
Data are M ± SD. n=24 control subjects; n=28 GDM subjects and significant difference is as follow: *p<0.05, **p<0.001.